These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2696525)

  • 21. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal and hydronephrotic kidney: evaluation of renal function with contrast-enhanced MR imaging.
    Kikinis R; von Schulthess GK; Jäger P; Dürr R; Bino M; Kuoni W; Kübler O
    Radiology; 1987 Dec; 165(3):837-42. PubMed ID: 3685363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
    Hoehn-Berlage M; Bockhorst K
    Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basic physics of MR contrast agents and maximization of image contrast.
    Hendrick RE; Haacke EM
    J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron-dextran as a magnetic susceptibility contrast agent: flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain.
    White DL; Aicher KP; Tzika AA; Kucharczyk J; Engelstad BL; Moseley ME
    Magn Reson Med; 1992 Mar; 24(1):14-28. PubMed ID: 1313524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrovascular transit characteristics of DyDTPA-BMA and GdDTPA-BMA on normal and ischemic cat brain.
    Kucharczyk J; Asgari H; Mintorovitch J; Vexler Z; Rocklage S; Watson A; Moseley M
    AJNR Am J Neuroradiol; 1993; 14(2):289-96. PubMed ID: 8456701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular mapping using albumin-(Gd-DTPA), an intravascular MR contrast agent, and projection MR imaging.
    Moseley ME; White DL; Wang SC; Wikström MG; Dupon JW; Gobbel G; Roth K; Brasch RC
    J Comput Assist Tomogr; 1989; 13(2):215-21. PubMed ID: 2925907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative renal cortical perfusion in human subjects with magnetic resonance imaging using iron-oxide nanoparticles: influence of T1 shortening.
    Morell A; Ahlstrom H; Schoenberg SO; Abildgaard A; Bock M; Bjørnerud A
    Acta Radiol; 2008 Oct; 49(8):955-62. PubMed ID: 18615336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement.
    Wendland MF; Saeed M; Yu KK; Roberts TP; Lauerma K; Derugin N; Varadarajan J; Watson AD; Higgins CB
    Magn Reson Med; 1994 Sep; 32(3):319-29. PubMed ID: 7984064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional magnetic resonance imaging of the kidney using macromolecular contrast agents.
    Choyke PL; Kobayashi H
    Abdom Imaging; 2006; 31(2):224-31. PubMed ID: 16283582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MR imaging.
    Saeed M; Higgins CB; Geschwind JF; Wendland MF
    Eur Radiol; 2000; 10(2):310-8. PubMed ID: 10663763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal and systemic pH imaging by contrast-enhanced MRI.
    Raghunand N; Howison C; Sherry AD; Zhang S; Gillies RJ
    Magn Reson Med; 2003 Feb; 49(2):249-57. PubMed ID: 12541244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood.
    Weisskoff RM; Kiihne S
    Magn Reson Med; 1992 Apr; 24(2):375-83. PubMed ID: 1569876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-pass evaluation of renal perfusion with TurboFLASH MR imaging and superparamagnetic iron oxide particles.
    Trillaud H; Grenier N; Degreze P; Louail C; Chambon C; Franconi JM
    J Magn Reson Imaging; 1993; 3(1):83-91. PubMed ID: 8428106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of a superparamagnetic iron oxide (Resovist) for MR imaging of human cerebral blood volume.
    Reimer P; Schuierer G; Balzer T; Peters PE
    Magn Reson Med; 1995 Nov; 34(5):694-7. PubMed ID: 8544689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metal chelates as urographic contrast agents for magnetic resonance imaging. A comparative study.
    Marotti M; Schmiedl U; White D; Ramos E; Johnson T; Engelstad B
    Rofo; 1987 Jan; 146(1):89-93. PubMed ID: 3027795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of zonal renal ischemia with contrast-enhanced MR imaging with a macromolecular blood pool contrast agent.
    Vexler VS; Berthèzene Y; Clément O; Mühler A; Rosenau W; Moseley ME; Brasch RC
    J Magn Reson Imaging; 1992; 2(3):311-9. PubMed ID: 1627866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relaxation efficacy of paramagnetic and superparamagnetic microspheres in liver and spleen.
    Fahlvik AK; Holtz E; Klaveness J
    Magn Reson Imaging; 1990; 8(4):363-9. PubMed ID: 2392024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yb-DTPA, a novel contrast agent in magnetic resonance imaging: application to rat kidney.
    Sarkar SK; Rycyna RE; Lenkinski RE; Solleveld HA; Kinter LB
    Magn Reson Med; 1991 Feb; 17(2):328-35. PubMed ID: 2062207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional MR of the kidney.
    Frank JA; Choyke PL; Austin HA; Girton ME
    Magn Reson Med; 1991 Dec; 22(2):319-23. PubMed ID: 1812364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.